Entero Healthcare Solutions Limited (NSE:ENTERO)

Market Cap	50.60B -11.2%
Revenue (ttm)	56.73B +28.2%
Net Income	1.11B +54.7%
EPS	25.36 +37.4%
Shares Out	43.51M
PE Ratio	45.86
Forward PE	29.97
Dividend	n/a
Ex-Dividend Date	n/a

Volume	24,334
Average Volume	84,533
Open	1,163.00
Previous Close	1,162.90
Day's Range	1,135.00 - 1,184.80
52-Week Range	944.00 - 1,510.80
Beta	-0.17
RSI	53.92
Earnings Date	Feb 12, 2026

About NSE:ENTERO

Entero Healthcare Solutions Limited engages in the distribution and marketing of pharmaceutical, surgical products and other allied services in India. The company involved in the distribution of generic formulations, active pharmaceutical ingredients, surgical consumables, rehabilitation products and devices, over the counter medical products, nutraceuticals, biosimilars, and biologics. It also provides nebulizers, personal protective, hygiene and surgical consumable products, homecare medical devices, gloves and mobility equipment, digital the...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2018
• Employees: 4,111
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ENTERO

Financial Performance

In fiscal year 2025, NSE:ENTERO's revenue was 50.96 billion, an increase of 29.92% compared to the previous year's 39.22 billion. Earnings were 948.20 million, an increase of 142.45%.